Pre-Cure is transforming cancer treatment selection through a predictive, biopsy-based 3D functional platform. By evaluating each patient’s individual tumor response, our drug-prioritization test identifies the therapies most likely to be effective and supports the selection of the right treatment from the very first line. Pre-Cure aims to improve patient outcomes while reducing ineffective treatment cycles.
| Website | https://www.pre-cure.bio/ |
| Employees | 8 (6 on RocketReach) |
| Founded | 2023 |
| Phone | +1 617-892-9080 |
| Industry | Biotechnology Research |
| Keywords | Cancer Treatment, Personalized Medicine, Organ On A Chip, Precision Oncology, 3d Cell Culture, In Vitro Models, Cancer Research, Cancer Therapies, Oncology, Cancer Diagnostics, Disease Modeling, Therapeutic Solutions, Drug Discovery, Drug Development, Biomedical Engineering, Pharmaceutical Research, Biotechnology, Medical Technology |
| Competitors | Novartis, Pfizer, Sanofi, GSK, AstraZeneca, Genentech, Moderna Therapeutics, Kite Pharma, CureVac, RaNA Therapeutics +44 more (view full list) |
Looking for a particular Pre-Cure employee's phone or email?
Dan Simhon is the Co-founder and CEO of Pre-Cure.
6 people are employed at Pre-Cure.